Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

SLN

Silence Therapeutics plc

Healthcare · Pharmaceutical Preparations

$11.20Sep 28, 2026

AI confidence 50% · prior close shown (market closed)

Investment Snapshot

Limited proprietary earnings coverage for SLN yet — signals will sharpen as filings and earnings are ingested.

Pipeline evidence · 79d ago

SLN's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on SLN.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest Intelligence

Updated

What happened recently for Silence Therapeutics plc (SLN) — events, not interpretation.

Event
Last session September 28, 2026 at $11.2.
Source
Market data

Research & analysis only — not investment advice.

Building company intelligence…

Silence Therapeutics plc (SLN)

Healthcare · Pharmaceutical Preparations

Investment Snapshot above is the primary AlphaOS analysis for Silence Therapeutics plc — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:
Healthcare
Market cap:
$1.53B
Revenue:
$559,000

SLN earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Silence Therapeutics plc through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.